Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04040933 · ClinicalTrials.gov registry record · NA
A Study to Assess Wound Healing Efficacies of Different Adhesive Bandages
A NA study, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT04040933: Completed NA study, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).
NCT04040933 is a NA study that has completed, run by Johnson & Johnson Consumer Inc. (J&JCI). The registered enrollment target is 36 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04040933, a NA study, has completed, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the wound healing efficacy (time to complete healing) of different adhesive bandages.
Primary Outcome
Time to complete wound healing: time(in days) elapsed from time of wound creation to 12 PM of day (up to Day 16) on which composite healing score(CHS) first meets complete healing criterion of being at least a score of 8 (threshold for complete healing). CHS was calculated from clinical grading of wound healing parameters as general wound appearance (0 \[Poor-New or fresh wound with epithelium layer missing, wound bed appears raw and possibly oozing\] to 4 \[Excellent-Fully healed, skin flush ag
Interventions
- DEVICE Marketed Adhesive Bandage #1
- DEVICE Marketed Bandage #2
- DEVICE Non-Marketed Bandage #1
- DEVICE Non-Marketed Bandage #2
- DEVICE Non-Marketed Adhesive Bandage #3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2019-08-09 |
| Est. Completion | 2019-10-30 |
| Phase | NA |
What the finished NCT04040933 record still lists
NCT04040933 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 5 interventions - of which Marketed Adhesive Bandage #1 is the first listed.
NCT04040933 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04040933 about?
NCT04040933 is a clinical study titled "A Study to Assess Wound Healing Efficacies of Different Adhesive Bandages". The purpose of this study is to assess the wound healing efficacy (time to complete healing) of different adhesive bandages.
What is the current status of trial NCT04040933?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2019-08-09. Estimated completion is 2019-10-30.
What interventions are being tested in trial NCT04040933?
The interventions under investigation include: Marketed Adhesive Bandage #1 (DEVICE), Marketed Bandage #2 (DEVICE), Non-Marketed Bandage #1 (DEVICE), Non-Marketed Bandage #2 (DEVICE), Non-Marketed Adhesive Bandage #3 (DEVICE).
Who is sponsoring clinical trial NCT04040933?
This trial is sponsored by Johnson & Johnson Consumer Inc. (J&JCI), which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04040933's enrollment target sits among peer trials
36 1541st of 2000 higher than 437 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI